Filgrastim Terminated Phase 2 Trials for Leukemia Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03381118Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients